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Use of wearable sensors to assess 
compliance of asthmatic children 
in response to lockdown measures 
for the COVID‑19 epidemic
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Between March and April 2020, Cyprus and Greece health authorities enforced three escalated levels 
of public health interventions to control the COVID‑19 pandemic. We quantified compliance of 108 
asthmatic schoolchildren (53 from Cyprus, 55 from Greece, mean age 9.7 years) from both countries 
to intervention levels, using wearable sensors to continuously track personal location and physical 
activity. Changes in ‘fraction time spent at home’ and ‘total steps/day’ were assessed with a mixed‑
effects model adjusting for confounders. We observed significant mean increases in ‘fraction time 
spent at home’ in Cyprus and Greece, during each intervention level by 41.4% and 14.3% (level 1), 
48.7% and 23.1% (level 2) and 45.2% and 32.0% (level 3), respectively. Physical activity in Cyprus and 
Greece demonstrated significant mean decreases by − 2,531 and − 1,191 (level 1), − 3,638 and − 2,337 
(level 2) and − 3,644 and − 1,961 (level 3) total steps/day, respectively. Significant independent effects 
of weekends and age were found on ‘fraction time spent at home’. Similarly, weekends, age, humidity 
and gender had an independent effect on physical activity. We suggest that wearable technology 
provides objective, continuous, real‑time location and activity data making possible to inform in a 
timely manner public health officials on compliance to various tiers of public health interventions 
during a pandemic.
Following several coronavirus outbreaks during the last  years1, a novel coronavirus named SARS-CoV-2 pre-
sented in Wuhan, China in December 2019, causing severe disease (COVID-19) with high fatality rates, espe-
cially, amongst the elderly and people with  comorbidities2. The virus rapidly spread all over the world and on 
the 11th of March 2020, WHO characterized COVID-19 outbreak as a  pandemic3.
In the absence of an effective vaccine or specific antiviral drugs against COVID-194, it seems that the only 
strategy to control the pandemic are public health interventions implemented at the community or national 
level. The interventions may range from simple isolation of disease carriers, quarantine of contacts and hand 
hygiene measures to ban of mass gatherings, social distancing and finally to complete lockdown and community 
quarantine (cordon sanitaire)5–7. These measures coupled with extraordinary travel restrictions from national 
governments are often in disaccord with international and human rights  law8. During the first peak of the pan-
demic, affected countries chose different levels of interventions based, among others, on national risk assessments 
of estimated number of patients and capacity for hospitalization and critical care  support9,10. The evolution of 
the pandemic over the last months demonstrated that timely interventions were effective to delay the spread of 
COVID-1911,12, as it was also shown in previous flu and SARS  epidemics13–15.
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The compliance of the population to non-pharmaceutical interventions plays a catalytic role in the success-
ful containment of the  virus16. However, it is difficult to monitor and understand population’s compliance to 
behavioural changes forced by interventions during an emerging  pandemic17–19. To date, several parameters have 
been used as indirect indicators of societal behaviour and compliance to public health measures, such as the 
reduction of outdoor  pollution20,21, decrease in traffic  accidents22 or even quietening of human activity signals 
as measured by seismometers  worldwide23. In the context of complete lockdown measures, where citizens are 
advised to reduce their mobility and stay at home, wearable sensors measuring physical activity levels and time 
spent at home may serve as a direct indicator for citizens’ compliance to the measures.
Patients with chronic respiratory disorders, like asthma, are considered to be at increased risk for severe 
COVID-19  disease24,25 and from the beginning of the pandemic they were advised to meticulously comply to 
restriction measures. In the pediatric population, asthma is the most common chronic disorder and although 
COVID-19 is milder in children, the burden of the disease on public health may be  significant26. Furthermore, 
it is known that children may have more difficulties to comply to restriction  measures27, with their compliance 
depending substantially on the whole family’s attitude towards the measures. The aim of our study was to quantify 
mobility changes in response to COVID-19 lockdown measures of schoolchildren with asthma in Cyprus and 
Greece, by continuously tracking their location and activity, using wearable sensors.
Results
Participants’ characteristics. For 2020 study period, a total of 108 (57% males) asthmatic children, 53 
in Cyprus and 55 in Greece, with an average age of 9.2 years were enrolled in the study, and contributed data 
between February 3rd and April 26th, 2020. All children had a physician’s diagnosis of asthma, while 53% also 
reported wheezing episode(s) during the past 12 months, 45% unscheduled medical visit(s) for asthma, 26% 
emergency room visits for asthma, and 20% daily preventive anti-asthma medication during the past 12 months. 
Among study participants, 43% were characterized as having asthma severity 1, 43% asthma severity 2 and 15% 
asthma severity 3 (Table 1). For the 2019 study period, from February 3rd to April 26th, we measured mobil-
ity for 39 and 52 asthmatic children (59% males) in Cyprus and Greece, respectively, with an average age of 
9.3 years.
Unadjusted analysis. Overall, in both countries there were significant changes in the observed fraction 
time spent at home and total steps/day with introduction of public health intervention levels for the study year 
2020. The observed mean fraction time spent at home among asthmatic children in Cyprus and Greece during 
baseline period was 43.8% (95%CI: 40.5–47.1%) and 52.4% (95%CI: 49.4–55.4%) respectively. In Cyprus, the 
observed fraction time spent at home significantly increased to 88.9% (95%CI: 85.7–92.1%) during level 1, to 
95.5% (95%CI: 93.8–97.2%) during level 2 and 94.1% (95%CI: 92.5–95.7%) during level 3 of interventions. In 
Greece, introduction of level 1 public health interventions was characterized by an increase in the observed frac-
tion time spent at home to 71.4% (95%CI: 60.4–82.5%), while during level 2 and 3 interventions the fraction time 
spent at home increased further to 84.9% (95%CI: 80.3–89.4%) and 89.6% (95%CI: 87.0–92.3%) respectively 
(Table 2, Fig. 1). In Cyprus, the observed total steps/day reduced significantly with introduction of each level 
of public health interventions from 8,996 (95%CI: 8,567–9,425) at baseline, to 6,499 (95%CI: 5,832–7,166) at 
Table 1.  Basic demographic and clinical characteristics of asthmatic children in Cyprus and Greece included 
in the study for the 2020 study period. *Values are presented as Mean (Standard Deviation). †ER: Emergency 
Department. ‡ Asthma Severity 1: Physician diagnosis plus one other eligibility criterion, Asthma Severity 2: 
Physician diagnosis plus two other eligibility criteria, Asthma Severity 3: Physician diagnosis plus three or 
more other eligibility criteria.
Parameter Asthmatic children (Cyprus, n = 53) Asthmatic children (Greece, n = 55)
Demographic
M (%) 35 (66%) 27 (49%)
Age, years* 9.3 (1.7) 9.11 (1.8)
Weight, kg* 39.3 (19.0) 35.9 (9.6)
Height, cm* 137.2 (21) 134.8 (10.2)
BMI, kg/m2* 20.3 (8.3) 19.5 (3.3)
Asthma eligibility criteria
Physician diagnosis of Asthma 53 (100%) 55 (100%)
Wheezing episodes 35 (66%) 22 (40%)
Daily preventive medication 10 (19%) 12 (22%)
Unscheduled physician visits for Asthma 34 (64%) 15 (27%)
ER† visits for Asthma 10 (19%) 18 (33%)
Asthma severity status‡
Asthma severity 1 25 (47%) 21 (38%)
Asthma severity 2 20 (38%) 26 (47%)
Asthma severity 3 8 (15%) 8 (15%)
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Table 2.  Observed fraction time spent at home and total steps per day across levels of intervention for Covid-
19 in Cyprus and Greece. Values are presented as mean (95% Confidence Interval).
Intervention
Parameter Statistical significance Parameter Statistical significance
Fraction time spent at 
home Compared to baseline
Compared to 
previous level Steps per day Compared to baseline
Compared to 
previous level
Asthmatic children (Cyprus) (n = 53)
Baseline (Level 0) 43.8% (40.5%; 47.1%) – – 8996 (8567; 9425) – –
Level 1 88.9% (85.7%; 92.1%)  < 0.001  < 0.001 6499 (5832; 7166)  < 0.001  < 0.001
Level 2 95.5% (93.8%; 97.2%)  < 0.001 0.151 6248 (5683; 6812)  < 0.001 0.999
Level 3 94.1% (92.5%; 95.7%)  < 0.001 0.999 6270 (5814; 6727)  < 0.001 0.999
Fraction time spent at home Steps per day
Asthmatic children (Greece) (n = 55)
Baseline (Level 0) 52.4% (49.4%; 55.4%) – – 8527 (8145; 8908) – –
Level 1 71.4% (60.4%; 82.5%) 0.003 0.003 6864 (5689; 8040) 0.060 0.060
Level 2 84.9% (80.3%; 89.4%)  < 0.001 0.357 5533 (4769; 6297)  < 0.001 0.613
Level 3 89.6% (87.0%; 92.3%)  < 0.001 0.999 5439 (5051; 5829)  < 0.001 0.999
Figure 1.  Changes in mobility in response to public health interventions among asthmatic children. 
Weekly averages of fraction time spent at home and steps/day, before and during three levels of public health 
interventions in asthmatic children in Cyprus (A) and Greece (B).
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level 1, 6,248 (95%CI: 5,683–6,812) at level 2 and 6,270 (95%CI: 5,814–6,727) at level 3. Similarly, in Greece, the 
observed total steps/day reduced with each level of public health interventions from 8,527 (95%CI: 8,145–8,908) 
at baseline, to 6,864 (95%CI: 5,689–8,040) at level 1, 5,533 (95%CI: 4,769–6,297) at level 2 and 5,439 (95%CI: 
5,051–5,829) at level 3 (Table 2, Fig. 1). The same trend was also observed for fraction time spent at home and 
total steps per day in both countries when the change across levels of intervention were calculated separately 
for each category of asthma severity. Data are presented in detail in Supplementary Table 1. This pattern was in 
sharp contrast to the normal mobility pattern of the asthmatic children cohorts in Cyprus and Greece during the 
same study period for the study year 2019, where the fraction time spent at home and total steps per day were 
quite stable throughout the same weeks of the year (Fig. 2).
Adjusted analysis. Based on the mixed effects model, after controlling for several confounders, the adjusted 
mean increase in time-fractions spent at home in Cyprus were: 41.4% (95%CI: 34.5–48.2%, pvalue < 0.001 com-
pared to baseline) during level 1, 48.7% (95%CI: 42.0–55.5%, pvalue < 0.001 compared to baseline) during level 
2, and 45.2% (95%CI: 39.3–51.2%, pvalue < 0.001 compared to baseline) during level 3 of interventions (Table 3). 
There was no significant increase between level 2 and 3 periods (pvalue = 0.298), while the increase between level 
1 and 2 periods was almost significant (pvalue = 0.055). In Greece, the adjusted mean changes in fraction time 
spent at home were more gradual and moderate, increasing by 14.3% (95%CI: 2.2–26.3%, pvalue = 0.02 com-
pared to baseline) during level 1, 23.1% (95%CI: 11.2–34.9%, pvalue < 0.001 compared to baseline) during level 2, 
and 32.0% (95%CI: 24.8–39.3%, pvalue < 0.001 compared to baseline) during level 3 interventions (Table 4). The 
changes between levels 1 and 2 as well as levels 2 and 3 were not statistically significant.
In Cyprus, physical activity, expressed in total steps per day, demonstrated an adjusted mean decrease of − 2,531 
(95%CI: − 3,364; − 1,698, pvalue < 0.001 compared to baseline) during level 1, − 3,638 (95%CI: − 4,521; − 2,755, 
Figure 2.  Comparison of mobility of asthmatic children recorded in February–April 2019 and February–April 
2020 in Cyprus and Crete. Weekly averages of fraction time spent at home and steps/day during the same period 
of 2019 and 2020 in Cyprus (A) and Greece (B) (February–April).
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pvalue < 0.001 compared to baseline) during level 2, and − 3,644 (95%CI: − 4,428; − 2,859, pvalue < 0.001 compared 
to baseline) during level 3 (Table 3). The decreases in total steps per day for levels 1 and 2 were statistically sig-
nificant (pvalue = 0.019), but not for levels 2 and 3 (pvalue = 0.954). In Greece, the adjusted mean decrease of physical 
activity during level 1 period was − 1,191 (95%CI: − 2,641; − 259, pvalue = 0.108 compared to baseline) steps per 
day. During level 2 and 3 periods the corresponding decreases were − 2,337 (95%CI: − 3,679; − 995, pvalue = 0.001 
compared to baseline) and − 1,961 (95%CI: − 2,933; − 990, pvalue < 0.001 compared to baseline) steps/day, respec-
tively (Table 4). The differences in total steps decreases per day between levels 1 and 2 (pvalue = 0.212) and levels 
2 and 3  (pvalue = 0.576) did not reach statistical significance.
During the baseline period, in the cohort of asthmatic children in Cyprus, we found that fraction time 
spent at home was significantly higher during weekends as compared to weekdays (mean increase compared to 
weekdays: 10.9%. 95%CI: 8.0; 13.8%) and with every year of increasing age (mean increase: 1.4%. 95%CI: 0.2; 
2.6%). Furthermore, total steps per day were significantly lower during weekends (mean decrease compared 
to weekdays: − 1,002. 95%CI: − 1,374; − 630), with increasing age (mean decrease: − 378. 95% CI: − 615; − 143), 
increasing humidity (mean decrease: − 29. 95%CI: − 42; − 15) and in year 2020 as compared to year 2019 
(mean decrease: − 1,560. 95%CI: − 2,796; − 324). Finally, total steps per day were significantly higher in males 
as compared to females (mean increase: 1,024. 95%CI: 53; 1,944) (Table 3). In asthmatic children in Greece, 
Table 3.  Fraction time spent at home and total steps per day in response to interventions for Covid-19 among 
asthmatic children in Cyprus. *p < 0.001, compared to previous level. †p = 0.055, compared to the previous level. 
‡p = 0.021, compared to the previous level, §p > 0.05, compared to the previous level.
Parameter
Fraction time spent at home Total Steps per day
β coefficient (95% CI) Compared to baseline β coefficient (95% CI) Compared to baseline
Baseline (Level 0) (intercept) 47.1% (18.2%; 76.0%) – 13,520 (9123–17,917) –
Level 1 41.4% (34.5%; 48.2%)  < 0.001*  − 2531 (− 3364; − 1698)  < 0.001*
Level 2 48.7% (42.0%; 55.5%)  < 0.001†  − 3638 (− 4521; − 2755)  < 0.001‡
Level 3 45.2% (39.3%; 51.2%)  < 0.001§  − 3644 (− 4428; − 2859)  < 0.001§
Gender (male) 1.7% (− 3.2%; 6.5%) 0.502 1024 (53;1944) 0.039
Age (per year increase) 1.4% (0.2%; 2.6%) 0.019  − 378 (− 615; − 143) 0.002
Year (2020)  − 0.6% (− 6.4%; 5.1%) 0.826  − 1560 (− 2796; − 324) 0.013
Weekend 10.9% (8.0%; 13.8%)  < 0.001  − 1002 (1374; − 630)  < 0.001
Temperature (per degree  C0 
increase)  − 0.03% (− 0.07%; 0.15%) 0.909 58.0 (− 6; 122) 0.075
Humidity (per % increase 0.04% (− 0.07%; 0.15%) 0.539  − 29 (− 42; − 15)  < 0.001
Interaction term β coefficient (95% CI) Compared to baseline β coefficient (95% CI) Compared to baseline
Weekend # Level 1  − 22.8% (− 33.8%; − 11.8%)  < 0.001 1870 (539; 3202) 0.006
Weekend # Level 2  − 13.0% (− 25.9%; − 0.1%) 0.047 1196 (− 535; 2927) 0.176
Weekend # Level 3  − 18.6% (− 27.4%; − 9.8%)  < 0.001 1361 (191; 2531)  < 0.001
Table 4.  Fraction time spent at home and total steps per day in response to interventions for Covid-19 among 
asthmatic children in Greece. *p = 0.020, compared to previous level. †p > 0.05, compared to the previous level.
Parameter
Fraction time spent at home Total Steps per day
β coefficient (95% CI) Compared to baseline β coefficient (95% CI) Compared to baseline
Baseline (Level 0) (intercept) 74.6% (52.3%; 97.0%) – 13,342 (9182; 17,501) –
 Level 1 14.3% (2.2%; 26.3%) 0.020*  − 1191 (− 2641; − 259) 0.108†
 Level 2 23.1% (11.2%; 34.9%)  < 0.001†  − 2337 (− 3679; − 995) 0.001†
 Level 3 32.0% (24.8%; − 39.3%)  < 0.001†  − 1961 (− 2933; − 990)  < 0.001†
Gender (male) 2.2% (− 3.4%; 7.7%) 0.442 1064 (− 63; 2191) 0.064
Age (per year increase)  − 1.0% (− 2.6%; 0.5%) 0.191 57 (− 257; 370) 0.722
Year (2020)  − 0.7% (− 7.9%; 6.6%) 0.859  − 2791 (− 4090; − 1492)  < 0.001
Weekend 8.32% (5.2%; 11.4%)  < 0.001  − 1212 (1615; − 809)  < 0.001
Temperature (per degree  C0 
increase)  − 0.6% (− 1.3%; 0.0%) 0.059 21 (− 64; 107) 0.628
Humidity (per % increase)  − 0.1% (− 0.2%; 0.0%) 0.061  − 2 (− 16; 12) 0.763
Interaction term β coefficient (95% CI) Compared to baseline β coefficient (95% CI) Compared to baseline
Weekend # Level 1  − 12.7% (− 37.2%; − 11.8%) 0.310 149 (− 2739; 3037) 0.006
Weekend # Level 2  − 9.5% (− 32.5%; 13.5%) 0.416 3704 (1115; 6292) 0.005
Weekend # Level 3  − 9.6% (− 19.8%; 0.5%) 0.063 1433 (96; 2772) 0.036
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the fraction of time spent at home was also found to be significantly higher during weekends as compared 
to weekdays (mean increase: 8.32%. 95%CI: 5.2; 11.4%), while steps per day were significantly lower during 
weekends (mean decrease: − 1,212. 95%CI: − 1,615; − 809) and in year 2020 as compared to year 2019 (mean 
decrease: − 2,791. 95%CI: − 4,090; − 1,492) (Table 4). In asthmatic children in Cyprus, we found a significant 
interaction effect of weekends across all levels of interventions on both the fraction time spent indoors and 
total steps per day. The effect of weekends on fraction time spent indoors changed, significantly, from positive 
during level 0 (mean increase: 10.9%) to negative during level 1 (mean decrease: − 22.8%, pvalue: < 0.001), level 2 
(mean decrease: − 13.0%, pvalue: 0.047) and level 3 (mean decrease: − 18.6%, pvalue: < 0.001). A similar interaction 
effect was observed on the effect of weekends on total steps per day which changed from negative during level 
0 (mean decrease: − 1002) to positive during level 1 (mean increase: 1863, pvalue: 0.006), level 2 (mean increase: 
1180, pvalue: 0.181) and level 3 (mean increase: 1359, pvalue: < 0.023), (Table 3). In asthmatic children in Greece 
we found a significant interaction effect for weekends only in regards to total steps per day. During the baseline 
period, weekends were associated with a mean decrease of − 1212 steps per day while this effect was reversed in 
level 1 (mean increase: 149, pvalue: 0.919), level 2 (mean increase: 3704, pvalue: 0.005) and level 3 (mean increase: 
1434, pvalue: 0.036), (Table 4).
Discussion
In this study, we have assessed changes in mobility of asthmatic children in Cyprus and Greece in response to 
different levels of public health interventions for the COVID-19 pandemic using GPS tracking, pedometer and 
heart rate sensors embedded in wearable watches. Our data imply that asthmatic children in both countries were 
highly compliant to public health measures, by changing their everyday routine and limiting their activity and 
mobility outside their homes.
In asthmatic children in Cyprus, we recorded a steep increase in the fraction of time spent at home from 
44% to the very high 95% and a steep decrease in total steps per day from 8,996 to 6,270, demonstrating high 
compliance to the implemented three levels of interventions. In asthmatic children in Greece, we observed a 
more gradual, stepwise increase in fraction time spent at home from 52% at baseline to the also high 90% and 
a similar pattern of gradual decrease of physical activity from 8,527 to 5,439 steps/day. The subtle differences in 
the findings between the two countries can be explained by differences in the actual measures implemented in 
each country rather than by real differences in the compliance of asthmatic children to the interventions. In fact, 
intervention measures in Greece were slightly different to those in Cyprus. In Greece level 2 measures included 
only ban of public gatherings and closure of shops and worship places, and escalated to include personal transport 
and movement restrictions only in level 3 period. In Cyprus, personal mobility restrictions were implemented 
from level 2 measures and became stricter (only one movement per day) in level 3, although the corresponding 
changes in fraction time spent at home and steps per day between level 2 and level 3 periods were not significant 
in our study group.
The successful management of the pandemic spread in Cyprus and Greece is probably due to the early intro-
duction of lockdown measures in both countries by March 25 and 23, 2020 respectively, and the high compli-
ance of vulnerable groups, and possibly the general population, who spent the majority of their time at home. 
The effectiveness of lockdown measures to reduce transmission of COVID-19 in several European countries 
including Greece was previously  reported28. A recent modelling study evaluated the impact of the sequence of 
restrictions posed to mobility and human-to-human interactions on the virus transmission in Italy and found 
that they have reduced transmission by 45%29. As of 26 April 2020, 1.43 and 1.22 deaths per 100,000 popula-
tion were reported for Cyprus and Greece respectively, which places them among the countries with the lowest 
mortality rates for COVID-19 in the EU/EEA and  UK30. Our findings may also relate to those of several recent 
studies that reported reduced asthma morbidity in children during the COVID-19 pandemic, attributed to the 
reduction of the overall viral infections because of significant changes in their daily  activity31–34.
It is well documented that wearable technology is a reliable, objective tool for monitoring numerous dis-
eases and estimating adherence to  medication35. However, to the best of our knowledge, there are no previ-
ous studies examining compliance to public health interventions using wearable devices. Previous reports on 
adherence to public health interventions during epidemics were based on telephone or mailed interviews and 
 questionnaires17–19,36. These conventional tools have inherent limitations such as non-response, recall biases, lack 
of validation of self-reports, influence by concerns about being recognized as breaching quarantine and low-level 
spatio-temporal information. In contrast, the use of wearable devices provides objective, continuous, real-time 
location and activity data making possible to timely inform public health officials on the results of various tiers 
of public health interventions and ensure adequate decision making in escalating or de-escalating interventions.
Using a mixed effects model, we were able to find independent quantitative effects of several factors on the 
time participants spent at home (weekends, increasing age) and their physical activity (weekends, increasing 
age, humidity and gender). We also found an interaction effect of weekends on higher fraction of time spent 
at home and lower physical activity, which was reversed during the implementation of intervention measures 
in both countries. One possible explanation is that, under normal conditions, families spend more time out of 
home on weekdays and more time at home during weekends. During the pandemic period this was reversed, as 
working parents and children had to work or study at home during weekdays and spend more time for outdoor 
activities on weekends. However, the change of participants’ daily behavior in both countries and the increase 
in their mobility on weekends during the enforcement of the lockdown measures requires further investigation. 
The independent effect of age on increasing fraction time spent at home and lower physical activity and female 
gender on lower physical activity in asthmatic children in Cyprus, agree with previous studies that reported 
lower physical activity in asthmatic  girls37 and older asthmatic  children38. Year 2020 has been associated with 
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lower physical activity in asthmatic children in both countries, which may relate to a systematic effect of either 
the recording devices used or implication of environmental factors we have not accounted for in the analysis.
Digital technology has been widely used in the COVID-19 management, including tracking positive cases, 
informing citizens about the current epidemiological status in their region, performing virtual clinics and diag-
nostics through telemedicine and in disease modelling using big data  analysis39,40. Our study presents another 
promising application of digital technology in the fight against the pandemic, by employing wearable sensors to 
provide objective and real-time information about population compliance to public health measures. Therefore, 
in a public health emergency, it is possible to employ wearable technology in a greater sample of the general 
population and enable rapid measurements of the public reaction to a particular set of interventions. GPS and 
physical activity data for example, are collected anonymously by telephone companies from their smartphone 
customers and theoretically may provide information about population’s attitude and adherence to interventions 
taken in pandemics and/or natural disasters. Towards this aim, in Israel a cell-phone tracking system was used 
in SARS-CoV-2 positive individuals to facilitate contacts  tracing41, while data from smartphone users in Italy 
have been analysed to estimate citizen mobility during the  lockdown42. In this direction, future applications of 
wearable digital technology may include the development of appropriate tools and infrastructure for efficient, 
systematic integration and interoperability of different health and behaviour data sources into existing public 
health systems. This approach will facilitate the link between symptom-tracking apps, behavior-tracking apps, 
contact tracing, aggregate population mobility monitoring, healthcare access and e-health  monitoring40.
Nevertheless, this kind of monitoring raises important ethical issues, as it could be considered as limiting 
individual freedoms and  rights43–46. In our case, monitoring of these patients with wearable devices was already 
established as part of the ongoing MEDEA project that started much before the spread of COVID-19, and thus 
we had obtained timely ethical approval and written consent from participants. In the case of pandemics, where 
decisions and measures are taken within days or even hours, it is extremely difficult to obtain fast-track consent 
from individuals to record their attitudes with wearable technology. For this reason, future health surveillance 
tracking and contact-tracing tools and applications should be designed in a way that can preserve individual 
freedoms and assert patient autonomy in a socially responsible manner, while educating the population about 
the positive effects of health  surveillance47.
An important limitation of wearable technology is the loss of signal of GPS tracking, especially in indoor 
environments, which introduces the challenge of how to treat missing values. As a response, automated micro-
environment classification algorithms that include spatial and temporal buffering have been developed and 
validated, especially for air pollution exposure  studies48 and provide an effective way to account for missing 
location data. Our findings should be interpreted with caution and not be generalized directly to all children 
or to the general population, because soon after the appearance of the COVID-19 pandemic it became widely 
known that asthmatic patients may be at increased risk for severe  disease49. Furthermore, asthmatic patients 
were more likely accustomed to protective behavioural changes even before the pandemic, as they were aware 
of the negative health effects of poor air  quality50,51 and the potential of atmospheric pollutants to further impair 
the respiratory system and facilitate viral infection, as it has been suggested for SARS-CoV-252. These factors 
may have led to increased compliance to public health intervention measures for COVID-19, as compared to 
the general population. Further studies, focusing on the general population are needed to better assess the full 
extent of population compliance to public health intervention measures for COVID-19. Finally, our cohort lacks 
information about family characteristics during the pandemic, such as parents’ employment status and time spent 
working from home, which may affect the outcomes of our study.
Conclusion
In conclusion, we implemented novel wearable technology methods to assess personal compliance to public 
health interventions aiming to contain the spread of a novel, highly contagious virus such as SARS-CoV-2. The 
successful implementation of public health interventions in Cyprus and Greece, which minimized COVID-19 
related mortality in both countries, was reflected in the sharp mobility reductions recorded in the participants 
of our study early in the course of the outbreak. Wearable devices provide objective, continuous, real-time data 
that may timely inform public health officials on compliance to various tiers of public health interventions and 
ensure informed decision-making and strategic planning in the containment of epidemics, both at national and 
cross-national levels.
Materials and methods
Study setting. Asthmatic children were recruited from primary schools in Cyprus and Greece (Heraklion 
district, Crete) and were enrolled in the ongoing LIFE-MEDEA public health intervention project (Clinical.
Trials.gov Identifier: NCT03503812). The LIFE-MEDEA project aims to evaluate the efficacy of behavioral rec-
ommendations to reduce exposure to particulate matter during desert dust storm (DDS) events and thus miti-
gate disease-specific adverse health effects in vulnerable groups of patients. Details of the study protocol and 
methods are presented in Supplementary File 1. In order to assess adherence to recommendations, participants 
are equipped with a wearable device (smartwatch) with several sensors. Participants are instructed to wear the 
smartwatch throughout the study period, during both DDS and non-DDS days. During non-DDS days, all par-
ticipants carry out their usual daily activities. The first MEDEA study period took place during February-June 
2019, the second study period during February-June 2020.
Study populations and recruitment. In the asthma panel study the target population were children aged 
from 6 to 11 years with mild to moderate persistent asthma. The eligibility criteria included a physician’s diagno-
sis of asthma and at least one of the following: daily preventative asthma medication, wheezing episodes and/or 
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unscheduled medical visits for asthma during the past 12 months. Basic demographic and clinical information 
from all participants was collected during the recruitment process. The number of eligibility criteria applying for 
each participant were used to categorize participants into asthma severity groups. The groups were defined as 
follows: Asthma Severity 1 (Physician diagnosis plus one other eligibility criterion), Asthma Severity 2 (Physi-
cian diagnosis plus two other eligibility criteria) and Asthma Severity 3 (Physician diagnosis plus three or more 
other eligibility criteria). In Cyprus, study approvals were obtained from the Cyprus National Bioethics Commit-
tee (EEBK EΠ 2017.01.141), the Data Protection Commissioner (No. 3.28.223) and the Ministry of Education 
(No 7.15.01.23.5). In Greece, approvals were obtained from the Scientific Committee (25/04/2018, No: 1748) 
and the Governing Board of the University General Hospital of Heraklion (25/22/08/2018). Guardians of all 
participants provided written informed consent and all methods described below were performed in accordance 
with the relevant guidelines and regulations.
Physical activity and GPS tracking. Physical activity and global positioning system (GPS) data were 
recorded between February 3 and April 26, for both study years (2019 and 2020) in Cyprus and Greece using 
the smartwatch. Data from study year 2020 were extracted to assess the participants’ mobility before and during 
the enforcement of COVID-19 lockdown measures while data from study year 2019 that represent a completely 
restrictions-free mobility period were also used for comparison. The EMBRACE™ smartwatch (Embrace Tech 
LTD, Cyprus) was used for data collection. The smartwatch works as a stand-alone device and is equipped with 
multiple sensors such as pedometer, GPS and heart rate as well as an embedded sim-card for Wi-Fi data trans-
fer. The software is capable of synchronizing the sensors, so the data are transferred to the cloud with the same 
timestamp. Data on GPS coordinates and steps/time unit, and heart rate are collected per 5-min intervals. Data 
synchronization with a cloud-based database is performed automatically when the smartwatch contacts the 
Wi-Fi network inside the participants’ home. For each participant we recorded the total number of steps per day 
(24-h period). In addition, we defined the fraction of time spent at home as the ratio of time with GPS signal 
within a 100 m radius around the participant’s residence divided by 24 h. The 100 m radius was defined as the 
maximum barrier to account for the accuracy of GPS signal in commercially available GPS  receivers53. As signal 
accuracy in urban and especially indoor environments is further blocked or bounced repeatedly off buildings 
prior to being  received54, we also classified 5-min intervals with no GPS signal as either “at-home” or “out-home”, 
depending on the signal of the most recent valid GPS recording. Lastly, the days that participants did not wear 
the smartwatch were identified by absence of heart rate measurements, and were excluded from subsequent 
analysis. We also excluded from the analysis GPS and pedometer data for DDS days in Cyprus (5 days during 
February-April 2020 and 4 days during February-April 2019) and Crete-Greece (1 day during February-April 
2020 and 2 days during February-April 2019) that may had further influenced the mobility of the participants.
Public health (non‑pharmaceutical) interventions in Cyprus and Greece. Data collection period 
spans for 12 weeks from February 3 to April 26, 2020 and was divided into four levels based on the implemented 
public health interventions in each country. In Cyprus, the first COVID-19 cases were identified on March 9, 
2020 and the study period is divided to: i) level 0 (baseline)—no public health interventions (Weeks 1–5: Febru-
ary 3, 2020–March 12, 2020), ii) level 1—social distancing measures, ban of public events with > 75 people, bars, 
restaurants and schools closed (Weeks 6–7: March 13, 2020–March 24, 2020), iii) level 2—all retail shops and 
worship places were closed, and mobility restrictions were implemented, except for subsistence and health needs 
(3 permissions per person per day) (Week 8: March 25, 2020–March 31, 2020), iv) level 3—stringent lockdown 
Figure 3.  Timeline of public health interventions in Cyprus and Greece. Timeline of the study recordings in 
relation to introduction of public health interventions in Cyprus (A) and Greece (B) during March–April 2020.
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with only one mobility permission per person per day (Weeks 9–12: April 01, 2020–April 26, 2020) (Fig. 3). In 
Greece, the first COVID-19 case was identified on February 26, 2020 and the study period is divided to: i) level 
0 (baseline)— no public health interventions (Weeks 1–5: February 03, 2020–March 10, 2020), ii) level 1—social 
distancing measures, ban of all public events, bars, restaurants and schools closed (Week 6: March 11, 2020–
March 15, 2020), iii) level 2—all retail shops and worship places closed, ban of gatherings of > 10 people (Week 7: 
March 16, 2020–March 22, 2020), iv) level 3—mobility restrictions except for subsistence and health needs (no 
daily limit) (Weeks 8–12: March 23, 2020-April 26, 2020) (Fig. 3).
Statistical analysis. Basic demographics and clinical characteristics of the asthmatic children were sum-
marized using mean (standard deviation) for continuous variables and percentages for categorical variables. 
In an unadjusted analysis, the mean fraction time spent at home and mean total steps per day were compared 
between the different periods of public health interventions using ANOVA, while graphs were constructed in 
order to demonstrate the weekly variation in mobility before and during the implementation of public health 
interventions in Cyprus and Greece. Furthermore, the course of fraction time spent at home and total steps per 
day in asthmatic children participating in the second MEDEA study period during February–April 2020 and 
the same parameters’ course in asthmatic children participating in the first MEDEA study period during Febru-
ary–April 2019 are displayed in separate graphs for Cyprus and Greece.
The changes in the daily levels of fraction time spent at home and total steps were further explored in a 
mixed effect model, which included a fixed effect term for the level of public health interventions and a random 
intercept for each participant. The mixed effect model was adjusted for the effect of age, gender, temperature, 
humidity, year, and weekend on mobility. In addition, sine and cosine functions were included to control for 
monthly variability in our data. Finally, for each parameter, we used an interaction term to test for differential 
change of mobility across the levels of interventions measures.
All statistical comparisons were performed using STATA 12 (StataCorp, TX) and a p value lower than 0.05 
was considered as statistically significant.
Data availability
A preprint of the manuscript is available under https ://www.resea rchsq uare.com/artic le/rs-37518 /v1. The original 
data are available under https ://zenod o.org/recor d/39064 45#.XvUBh G5uI2 w (https ://doi.org/10.5281/zenod 
o.39064 45).
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